Article
Pharmacogenomics of Lithium Response in Bipolar Disorder
24 Mar 2021
Abstract excerpt
Despite being the most widely studied mood stabilizer, researchers have not confirmed a mechanism for lithium’s therapeutic efficacy in Bipolar Disorder (BD). Pharmacogenomic applications may be clinically useful in the future for identifying lithium-responsive patients and facilitating personalized treatment. Six genome-wide association studies (GWAS) reviewed here present evidence of genetic variations related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
